Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Transgenomic Net Profit Margin 2010-2023 | PRPO

Transgenomic net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
  
Transgenomic Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $0.02B $-0.01B -31.25%
2023-09-30 $0.01B $-0.01B -57.14%
2023-06-30 $0.01B $-0.01B -90.91%
2023-03-31 $0.01B $-0.01B -111.11%
2022-12-31 $0.01B $-0.01B -150.00%
2022-09-30 $0.01B $-0.01B -150.00%
2022-06-30 $0.01B $-0.01B -137.50%
2022-03-31 $0.01B $-0.01B -150.00%
2021-12-31 $0.01B $-0.01B -100.00%
2021-09-30 $0.01B $-0.01B -100.00%
2021-06-30 $0.01B $-0.01B -112.50%
2021-03-31 $0.01B $-0.01B -114.29%
2020-12-31 $0.01B $-0.01B -233.33%
2020-09-30 $0.01B $-0.02B -320.00%
2020-06-30 $0.00B $-0.02B -375.00%
2020-03-31 $0.00B $-0.02B -475.00%
2019-12-31 $0.00B $-0.01B -350.00%
2019-09-30 $0.00B $-0.02B -425.00%
2019-06-30 $0.00B $-0.02B -475.00%
2019-03-31 $0.00B $-0.02B -400.00%
2018-12-31 $0.00B $-0.02B -500.00%
2018-09-30 $0.00B $-0.03B -650.00%
2018-06-30 $0.00B $-0.03B -1066.67%
2018-03-31 $0.00B $-0.04B -1900.00%
2017-12-31 $0.00B $-0.03B -3300.00%
2017-09-30 $0.00B $-0.02B -1900.00%
2017-06-30 $0.00B $-0.01B -900.00%
2017-03-31 $0.00B 0 0.00%
2016-12-31 $0.00B $-0.00B -150.00%
2016-09-30 $0.00B $-0.02B -2400.00%
2016-06-30 $0.00B $-0.03B -3200.00%
2016-03-31 $0.00B $-0.04B inf%
2015-12-31 $0.00B $-0.03B -3400.00%
2015-09-30 $-0.02B $-0.02B 133.33%
2015-06-30 $-0.01B $-0.01B 109.09%
2015-03-31 $-0.00B $-0.01B 325.00%
2014-12-31 $0.00B $-0.01B -1400.00%
2014-09-30 $0.02B $-0.01B -52.17%
2014-06-30 $0.03B $-0.02B -69.23%
2014-03-31 $0.03B $-0.02B -65.38%
2013-12-31 $0.03B $-0.02B -62.96%
2013-09-30 $0.03B $-0.02B -53.57%
2013-06-30 $0.03B $-0.01B -41.38%
2013-03-31 $0.03B $-0.01B -32.26%
2012-12-31 $0.03B $-0.01B -29.03%
2012-09-30 $0.03B $-0.01B -21.21%
2012-06-30 $0.03B $-0.01B -18.18%
2012-03-31 $0.03B $-0.01B -34.38%
2011-12-31 $0.03B $-0.01B -34.38%
2011-09-30 $0.03B $-0.01B -42.86%
2011-06-30 $0.02B $-0.01B -45.83%
2011-03-31 $0.02B $-0.01B -28.57%
2010-12-31 $0.02B $-0.00B -15.79%
2010-09-30 $0.02B $-0.00B -9.52%
2010-06-30 $0.02B $-0.00B -4.55%
2010-03-31 $0.02B $-0.00B -4.55%
2009-12-31 $0.02B $-0.00B -9.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.194B 0.00
IRhythm Technologies (IRTC) United States $3.483B 0.00
Axonics (AXNX) United States $3.401B 0.00
10x Genomics (TXG) United States $3.288B 0.00
Enovis (ENOV) United States $3.030B 23.02
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.840B 0.00
Hims & Hers Health (HIMS) United States $2.678B 0.00
Privia Health (PRVA) United States $2.167B 96.11
Schrodinger (SDGR) United States $1.733B 0.00
Omnicell (OMCL) United States $1.279B 31.30
Phreesia (PHR) United States $1.162B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.708B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.527B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
Clover Health Investments (CLOV) United States $0.337B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.328B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.153B 0.00
MSP Recovery (LIFW) United States $0.141B 0.00
P3 Health Partners (PIII) United States $0.141B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.03
111 (YI) China $0.086B 0.00
SHL Telemedicine (SHLT) Israel $0.082B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.048B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.035B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Akili (AKLI) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.018B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00